Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
about
Ten years of podoconiosis research in EthiopiaFilarial excretory-secretory products induce human monocytes to produce lymphangiogenic mediatorsA cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets WolbachiaAnti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasisComparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot TrialElevated adaptive immune responses are associated with latent infections of Wuchereria bancroftiCharacterization of transcription factors that regulate the type IV secretion system and riboflavin biosynthesis in Wolbachia of Brugia malayiPoint-of-Care Ultrasound Assessment of Tropical Infectious Diseases--A Review of Applications and Perspectives.Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells.Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesisLymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling.Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infectionsHorizontal gene transfer between bacteria and animals.Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.Current evidence on the use of antifilarial agents in the management of bancroftian filariasisLive Brugia malayi microfilariae inhibit transendothelial migration of neutrophils and monocytes.A randomized trial of doxycycline for Mansonella perstans infection.Filariasis and lymphoedema.Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifampicin plus DoxycyclineDevelopment and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.Filarial lymphatic pathology reflects augmented toll-like receptor-mediated, mitogen-activated protein kinase-mediated proinflammatory cytokine production.A feedback loop between Wolbachia and the Drosophila gurken mRNP complex influences Wolbachia titer.Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.Toll-like receptor- and filarial antigen-mediated, mitogen-activated protein kinase- and NF-κB-dependent regulation of angiogenic growth factors in filarial lymphatic pathology.Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus/Wolbachia-induced keratitis.Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.Immunopathogenesis of lymphatic filarial disease.Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesisMolecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme.Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.Insights into the pathogenesis of disease in human lymphatic filariasis.Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.Current practices in the management of lymphatic filariasis.
P2860
Q21144486-2C3F4BBA-4C05-4832-9BE1-FFA370A24A7CQ27304880-0511319E-BB2E-4EFC-9ACE-BEF2383FABD8Q27342384-E3188CC8-36C6-48C4-9A5B-AF627BC5BC23Q28294770-37D98235-95CD-461D-A761-C0E1DD63D42AQ28468411-DB5B2769-8BA6-4D53-B68A-CDA2494E65DDQ28482086-D6162569-254C-4FBA-BF4E-3C0C50E16CB9Q28484257-FC91ABDF-77EA-4148-8D04-A00CB2F53536Q30366003-400ADEE6-0963-4A79-B73C-E74DA0E381D2Q30377066-FB045AE2-FF5E-4BCB-8990-A4035C84DCEAQ33432759-A79FF737-6B6D-4425-8665-3083D2CEC26EQ33518439-25DBEDAE-B48C-4504-9245-A646D6F72036Q33518470-24C8F7C8-0FAF-43A3-956A-A029ABA3B79AQ33904958-84CF2A8A-BA51-499F-A046-08A6E9B9A251Q34160164-5D00E24E-151F-4DCB-91ED-A5FEA8815F46Q34165647-14DE2239-9752-4EF7-B66B-8CA6C98B4A28Q34243810-50C0AD27-6753-4263-AC14-FECE918AE6A9Q34277464-BEB82D07-C375-4923-B9A5-DC31C11EAD72Q34322310-AF8C26DE-7C6B-4999-BE8C-ADA7878C5A91Q34479159-E846D2B8-B936-4649-B9A7-B37E3192E91BQ34500870-5A262F98-59F9-4D42-BFD2-E938B5F148ABQ34612544-33D0383F-27B9-4B67-9532-5A07BB67EBCBQ34612712-3B8D5B53-DB0E-4D7A-8439-AEAD901CA4BDQ35038817-EC7E8D76-6C7D-487A-8482-ED5EC472EDFCQ35297570-AF8B2817-30CF-48C6-92EA-EB7F76672881Q35671666-6A0EB17A-595B-477A-8C59-8D5089E370E8Q35672139-A5A377A6-9402-4E71-A741-9CC746CE4D2AQ35689794-7A4BB243-9B57-43BA-81C7-1C2512169CB0Q36143298-113C2DC7-98B2-4F48-B49B-BBB739EE639BQ36156065-B297FAE7-DF5F-44F5-A464-6881EDBA43DAQ36314012-F1D682FD-4D8D-40D3-ADC6-A291AA6A44EFQ36376200-5E9A39C5-9E45-47D6-852D-FBF2B23F1BAAQ36400061-1D2BF74C-A445-45B5-97BF-DC7A276CB7CFQ36708214-80A465DF-ADAD-4F93-908A-F7F17A0381E3Q36732040-8476DFD1-7298-4141-8745-4198EF8466B2Q37036576-C4F2F37B-7E05-4D85-9D08-D1295859D0B8Q37157555-233432C4-4B87-4E37-BC80-EA858F3C35CDQ37190203-3AB81337-CAD3-43BA-87B1-F30396BF84E6Q37372289-77355537-221E-4960-9A13-18C0696D58FFQ37456187-BB50BC8A-6D61-4BF1-9B9C-59858E9C3DB1Q37503357-67193926-E42C-4A37-BC86-91028508ECEE
P2860
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@ast
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@en
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@nl
type
label
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@ast
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@en
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@nl
prefLabel
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@ast
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@en
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@nl
P2093
P2860
P1433
P1476
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
@en
P2093
Achim Hoerauf
Alexander Yaw Debrah
Bernard Lawson
John Larbi
Linda Batsa
Ohene Adjei
Sabine Mand
Sabine Specht
Yeboah Marfo-Debrekyei
P2860
P356
10.1371/JOURNAL.PPAT.0020092
P407
P577
2006-09-01T00:00:00Z